The findings of this study shed light on several key aspects of neurotrophic factor therapy for hearing loss induced by ototoxic insults, specifically focusing on the role of BDNF and its potential efficacy in mitigating cochlear damage induced by CDDP. The gene discussed is BDNF; the disease is hearing loss disorder.